|Bid||43.06 x 3100|
|Ask||43.17 x 3200|
|Day's range||42.63 - 43.19|
|52-week range||32.83 - 51.86|
|Beta (5Y monthly)||0.69|
|PE ratio (TTM)||18.43|
|Earnings date||02 Nov 2021|
|Forward dividend & yield||1.56 (3.61%)|
|Ex-dividend date||04 Nov 2021|
|1y target est||N/A|
Former U.S. Commerce Sec. Gary Locke weighs in on the global vaccine equity debate and how the U.S. can better respond to the ongoing pandemic.
Good news for a rival's coronavirus vaccine compounds worries about the company's shot.
Gary Locke, former U.S. Commerce Secretary, talks vaccine distribution, intellectual property, and why cold storage and personnel are critical to fighting COVID-19 around the world.